Adial Pharmaceuticals, Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Adial Pharmaceuticals, Inc. (ADIL) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 3.25 million shares for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2024-04-01
- Adial Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2023 was 3.25M shares, a 571.93% increase from fiscal 2022.
- Adial Pharmaceuticals, Inc. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2022 was 483.83K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|
| 2023-12-31 | 3.25M shares 10-K · filed 2024-04-01 | ||
| 2023-09-30 | 329.02K shares 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | 491.15K shares 10-Q/A · filed 2023-10-30 | ||
| 2022-12-31 | 483.83K shares 10-K · filed 2024-04-01 | ||
| 2022-09-30 | 483.83K shares 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | 483.83K shares 10-Q/A · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |